AXSOME THERAPEUTICS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
AXSOME THERAPEUTICS, INC. (AXSM) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $68.30 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-10
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $68.30M.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $82.80M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $99.10M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $112.60M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $68.30M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $82.80M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $99.10M 10-K · filed 2026-02-23 |
| 2025-09-30 | $112.60M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $133.80M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $148.80M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $146.60M 10-K · filed 2025-02-18 |
| 2024-09-30 | $160.90M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $177.50M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $198.40M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $162.00M 10-K · filed 2024-02-23 |
| 2023-09-30 | $160.60M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $153.30M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $160.30M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $95.70M 10-K · filed 2023-02-28 |
| 2022-09-30 | $97.70M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $90.30M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $91.00M 10-Q · filed 2022-05-02 |
| 2021-12-31 | $72.20M 10-K · filed 2022-03-01 |
| 2021-09-30 | $60.40M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $57.00M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $54.80M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $20.90M 10-K · filed 2021-03-01 |
| 2019-12-31 | $14.90M 10-K · filed 2020-03-12 |
| 2018-12-31 | $2.70M 10-K · filed 2019-03-15 |
| 2017-12-31 | $4.10M 10-K · filed 2018-03-07 |
| 2016-12-31 | $4.10M 10-K · filed 2017-03-07 |
| 2016-09-30 | $4.70M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $4.90M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.50M 10-Q/A · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |